Continuous glucose monitors have significantly altered the landscape of diabetes care in the UK and globally. By providing real-time, dynamic data about blood sugar levels, these devices allow individuals to move away from the disruptive and often painful routine of frequent finger-prick tests. However, recent research conducted at Bangor University highlights a critical, often overlooked blind spot in this technology. While these monitors excel at tracking day-to-day blood sugar management, they lose their ability to provide precise measurements during the most extreme hyperglycemic and hypoglycemic events. Understanding this limitation is essential for both patients and healthcare providers who rely on these devices for accurate health data.
Understanding the Mechanics of Continuous Glucose Monitors
To appreciate the limitations identified by researchers, it is necessary to first understand how continuous glucose monitors operate. A typical device consists of a small, flexible sensor inserted just beneath the skin, usually on the back of the upper arm. This sensor measures glucose levels in the interstitial fluid—the fluid between cells—rather than directly in the bloodstream. A transmitter attached to the sensor sends this data wirelessly to a smartphone or a dedicated receiver every few minutes.
This continuous stream of data offers several distinct advantages over traditional testing methods. Users can observe directional trend arrows indicating whether their blood sugar is rising, falling, or holding steady. They can set customizable alarms to alert them to impending high or low blood sugar levels before they become clinically dangerous. Furthermore, the aggregated data provides a comprehensive picture of how specific meals, physical activities, stress levels, and sleep patterns affect an individual’s metabolism. For many people living with type 1 or type 2 diabetes, this technology reduces the mental burden of constant calculation and guesswork.
Have questions about how this technology might fit into your daily routine? Write to us! We welcome discussions about the practical applications of health tech.
The Kitchen Thermometer Analogy: When Sensors Max Out
Despite their sophisticated engineering, continuous glucose monitors are bound by the same physical constraints as any other scientific instrument: they possess a finite measurement range. The Bangor University research team uses a highly effective analogy to explain this phenomenon—comparing the monitor to a standard kitchen thermometer that maxes out at 100 degrees Celsius.
If you place such a thermometer into boiling water, it will accurately read 100 degrees. However, if you place it into a hotter environment, such as an oven, the needle will simply peg at the maximum limit. The thermometer can tell you that the temperature is at least 100 degrees, but it cannot differentiate between 120 degrees and 250 degrees. Continuous glucose monitors function in exactly the same way when blood sugar moves beyond their calibrated limits.
Most modern continuous glucose monitors have an upper reporting limit—often around 400 mg/dL (22.2 mmol/L)—and a lower limit—often around 40 mg/dL (2.2 mmol/L). If a user’s blood sugar spikes to 500 mg/dL, the sensor will simply display “HIGH” or a comparable alert. Conversely, if it drops to 20 mg/dL, it will display “LOW.” The device successfully communicates that the patient is in a state of extreme metabolic imbalance, but it strips away the exact numerical severity of the event.
Key Findings from Bangor University UK Research
Dr. John Mulley, a Senior Lecturer in Zoology at Bangor University, led a team that sought to determine exactly how often this blind spot occurs in real-world scenarios. The researchers analyzed an enormous dataset comprising nearly 47 million individual continuous glucose monitor readings. This data was drawn from 948 individuals diagnosed with type 1 diabetes, sourced from four large-scale international clinical trials.
The findings were striking. Between 93.5% and 100% of participants across the four separate studies experienced at least one reading that hit either the upper or lower measurement limit of their device. This indicates that encountering the boundary of the monitor’s accuracy is not a rare edge case; it is a near-universal experience for individuals using these devices over an extended period.
The data revealed particularly concerning patterns regarding high blood sugar events. In three of the four trials evaluated, more than a third of the extreme high-glucose episodes remained pegged at the upper measurement limit for a minimum of one hour. For a typical participant, the longest single episode of this nature lasted between two and three hours. During these prolonged periods, the user and their medical team knew that blood sugar was dangerously high, but they had no way of knowing if it was marginally above the limit or exponentially higher.
Share your experiences in the comments below if you have ever encountered prolonged “HIGH” or “LOW” readings on your monitoring device.
Identifying High-Risk Demographics
The research also identified specific demographic patterns regarding who is most likely to encounter these measurement limits. Younger individuals experienced upper-limit readings significantly more frequently than older adults. This aligns with established clinical knowledge regarding the inherent difficulties of managing blood sugar during adolescence and young adulthood, a period often characterized by hormonal fluctuations, irregular dietary habits, and variable exercise routines.
Furthermore, the study found a strong correlation between baseline HbA1c levels and the frequency of hitting the sensor limits. HbA1c is a standard blood test that reflects average blood sugar levels over the preceding two to three months. Individuals with higher HbA1c levels—indicating poorer long-term blood sugar control—were substantially more likely to push their continuous glucose monitors to the absolute edge of their measurement capabilities. This creates a somewhat paradoxical situation: the patients who struggle the most with blood sugar management, and therefore need the most precise data to correct their course, are the most likely to have critical data stripped away during their most severe events.
Evaluating the Impact on Clinical Metrics
Faced with these findings, a critical question arises for diabetes care professionals: do these measurement limits invalidate the summary data used to assess a patient’s health? To answer this, the Bangor University researchers compared the continuous glucose monitor readings against simultaneous, traditional finger-prick blood glucose measurements.
The results offer a degree of reassurance. The researchers found that even when sensors regularly reached their upper or lower limits, the standard summary metrics utilized in clinical practice remained remarkably robust. Key performance indicators such as average glucose levels, glucose variability (the swings between highs and lows), and Time in Range (the percentage of the day a patient spends within their target glucose bracket) were largely unaffected by the loss of extreme data points.
This statistical resilience occurs because, even among participants who frequently experienced extreme highs and lows, the vast majority of their daily readings still fell comfortably within the sensor’s accurate measurement range. Therefore, the primary consequence of the sensor maxing out is not necessarily inaccurate aggregate statistics, but rather a localized loss of granular detail during the most extreme and potentially dangerous glucose events.
Explore our related articles for further reading on how clinical metrics are calculated and utilized in modern endocrinology.
The Clinical Significance of Lost Data
While the overall clinical metrics may remain stable, the loss of exact figures during extreme events carries genuine medical significance. In a clinical setting, knowing that a patient’s blood sugar reached 450 mg/dL rather than 410 mg/dL can change the immediate medical response. Higher extreme values may indicate a higher risk of developing diabetic ketoacidosis (DKA), a potentially life-threatening complication that requires urgent medical intervention.
Similarly, on the hypoglycemic end, distinguishing between a mild low of 60 mg/dL and a severe low of 30 mg/dL is vital. Severe hypoglycemia can lead to confusion, loss of consciousness, seizures, and in extreme cases, coma or death. When a monitor simply reads “LOW,” the patient or their caregiver must resort to guesswork or immediate finger-prick testing to determine the severity of the emergency and the appropriate dosage of fast-acting carbohydrates or glucagon required to treat it.
Recommended Software Improvements for Diabetes Care
The researchers at Bangor University propose a straightforward, highly actionable solution to mitigate this blind spot. Currently, the smartphone applications and web-based platforms that synthesize continuous glucose monitor data provide various graphs, averages, and daily reports. However, none of these platforms explicitly flag when a sensor has reached its measurement limit, how many times this occurred during a given period, or the cumulative duration of these limit-hitting events.
Integrating this information into existing software would require only a minor update to the user interface. By adding a clear visual indicator or a specific data column for “Time at Limit,” software developers could provide doctors and patients with a much more honest and complete picture of metabolic stability. This simple change would help healthcare providers quickly identify the individuals for whom this blind spot is most clinically relevant, allowing them to adjust treatment plans, modify insulin-to-carbohydrate ratios, or provide targeted education on preventing these extreme spikes and drops.
Practical Steps for Effective Blood Sugar Management
Until these software updates are universally implemented, patients and caregivers must adopt proactive strategies to manage the limitations of their continuous glucose monitors. First, it is important to recognize that seeing a “HIGH” or “LOW” reading is not a failure of the device, but rather an indication to shift monitoring strategies. When a sensor hits its limit, users should revert to traditional finger-prick testing to ascertain the exact severity of the event.
Second, patients should maintain open, transparent communication with their diabetes care teams regarding the frequency of these limit readings. If a patient notices that their reports consistently show prolonged periods at the upper limit, this is critical information that should be discussed during clinic appointments, even if the overall Time in Range metric looks acceptable. Adjusting basal insulin rates, evaluating bolus calculation strategies, or investigating underlying illness or insulin pump site failure may be necessary to prevent these extreme excursions.
Continuous glucose monitors remain one of the most important technological advancements in modern diabetes care. They drastically reduce the pain and inconvenience of testing, improve glycemic control, and provide unparalleled insights into daily metabolic patterns. The findings from Bangor University do not suggest that patients should abandon these devices. Rather, they serve as a reminder that all scientific instruments have operational boundaries. Recognizing when a glucose sensor has reached the edge of its capabilities empowers patients and clinicians to interpret data with appropriate skepticism during emergencies and take definitive, supplementary action when it matters most.
Are you interested in the intersection of technology and human health? Submit your application today to explore academic programs that drive innovation in medical research and patient care.
